LFG
NVAX icon

Larson Financial Group’s Novavax NVAX Stock Holding History

Larson Financial Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-300
Closed -$3K – 813
2020
Q3 		$3K Buy
+300
New +$36.5K ﹤0.01% 567

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Larson Financial Group's NVAX Position: Q1 2026 in Review

Larson Financial Group held its Novavax (NVAX) position steady in Q1 2026 at 195 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #3023.

Larson Financial Group first reported a position in NVAX in Q1 2020 and has held it in 23 quarters since. The position peaked at $165K in Q2 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Larson Financial Group held 195 shares of Novavax worth $1.59K as of Q1 2026.
  • Larson Financial Group left its Novavax share count unchanged in Q1 2026.
  • Novavax made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3023 holding.
  • Larson Financial Group first reported a position in Novavax in Q1 2020 and has held it in 23 quarters since.
  • Larson Financial Group's Novavax position peaked at $165K in Q2 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.